oxymatrine has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, DR; Jiang, W; Zhang, X; Zhao, M; Zhou, AL | 1 |
| Chen, C; Lei, L; Li, C; Li, Z; Ren, W; Su, Y; Xu, J; Yang, C | 1 |
2 other study(ies) available for oxymatrine and Acute Hepatic Failure
| Article | Year |
|---|---|
Inhibitory effect of oxymatrine on hepatocyte apoptosis
Topics: Alanine Transaminase; Alkaloids; Animals; Apoptosis; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Galactosamine; Glycogen Synthase Kinase 3 beta; Hepatocytes; Humans; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Microscopy, Electron, Transmission; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinolizines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2017 |
Protective effects of oxymatrine against lipopolysaccharide/D‑galactosamine‑induced acute liver failure through oxidative damage, via activation of Nrf2/HO‑1 and modulation of inflammatory TLR4‑signaling pathways.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Drug Evaluation, Preclinical; Galactosamine; Gene Expression; Glutathione Peroxidase; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Malondialdehyde; Membrane Proteins; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; Quinolizines; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |